Pharmaceutical Technology Excellence Awards 2024: BostonGene

BostonGene is a winner in four categories in the 2024 Pharmaceutical Technology Excellence Awards.

Nov 13, 2024 - 06:00

Pharmaceutical Technology Excellence Awards 2024: BostonGene

BostonGene is a winner in four categories in the 2024 Pharmaceutical Technology Excellence Awards.

Read the original article

Tags:

Previous Article

FDA grants breakthrough status to J&J’s nipocalimab for SjD treatment

MSD secures worldwide license for LaNova’s LM-299

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Nuvectis Pharma receives IND approval from FDA for NXP900

Nuvectis Pharma receives IND approval from FDA for NXP900

May 16, 2023

STAT+: Syndax’s leukemia drug succeeds in pivotal study

STAT+: Syndax’s leukemia drug succeeds in pivotal study

Oct 2, 2023

BMS licenses TCR-T immunotherapy therapy from Immatics

BMS licenses TCR-T immunotherapy therapy from Immatics

May 2, 2023